Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約6-8 週間 | ¥ 68,500 |
25 mg | 約6-8 週間 | ¥ 226,500 |
50 mg | 約6-8 週間 | ¥ 312,500 |
100 mg | 約6-8 週間 | ¥ 427,000 |
1 mL * 10 mM (in DMSO) | 約6-8 週間 | ¥ 84,000 |
説明 | Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death. |
ターゲット&IC50 | CDC7 (1 mM ATP):0.6 nM |
分子量 | 409.82 |
分子式 | C21H16ClN3O4 |
CAS No. | 1402055-25-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.2 mg/mL (12.69 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cdc7-IN-1 1402055-25-7 Cell Cycle/Checkpoint CDK Cdc7 IN 1 Cdc7IN1 Cdc-7-IN-1 Inhibitor inhibitor inhibit